Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), bought 20,000 shares at $32.48 ($650K) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market purchase of $650k PTCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.48 | 10,000 | $325K | 50.0% |
| 2 | $32.48 | 10,000 | $325K | 50.0% |
| Total | $32.48 avg | 20,000 | $650K | 100% |
| Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |
| PTCT | SELL | 2024-01-10 | $42K | — | Filing → |